US 8334373
Nuclease resistant double-stranded ribonucleic acid
granted A61PA61P43/00
Quick answer
US patent 8334373 (Nuclease resistant double-stranded ribonucleic acid) held by Alnylam Pharmaceuticals, Inc. expires Mon Dec 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Dec 18 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61P, A61P43/00